B. Thurner

发表

Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study

K. Roemer, A. Keren, D. Foell, 2022, The Lancet Rheumatology.

Autoantibodies against IL-1-receptor-antagonist in multisystem inflammatory syndrome in children

K. Roemer, D. Foell, S. Lohse, 2021, medRxiv.

Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19

K. Roemer, F. Lammert, D. Foell, 2021 .

Autoantibodies against Progranulin and IL-1 receptor antagonist due to immunogenic posttranslational isoforms contribute to hyperinflammation in critically ill COVID-19

K. Roemer, F. Lammert, D. Foell, 2021, bioRxiv.

Impairment of glucose metabolism in hearts from rats treated with endotoxin.

A. Lückhoff, B. Thurner, Y. Fischer, 2003, Cardiovascular research.

IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination

A. Keren, D. Foell, K. Stangl, 2022, The New England journal of medicine.

Autoantibodies against SUMO1-DHX35 in long-COVID

K. Heyne, R. Bals, C. Herr, 2022, Journal of Translational Autoimmunity.

Continuous intrathecal interferon alpha application in subacute sclerosing panencephalitis.

P. Spangenberg, S. Scheithauer, M. Häusler, 2007, The Pediatric infectious disease journal.

Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies

D. Foell, A. Tomelleri, C. Campochiaro, 2024, Journal of clinical immunology.